MUSCLE INVASIVE BLADDER CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial tests virus + drug combo for tough bladder cancers
Disease control CompletedThis small, early-stage study tested the safety of a two-part treatment for muscle-invasive bladder cancer in patients who could not receive standard chemotherapy. The treatment combined a modified cold virus (CG0070) placed directly into the bladder with an immunotherapy drug (n…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Double attack on tough bladder cancers shows promise
Disease control CompletedThis small pilot study tested whether combining an immunotherapy drug (pembrolizumab) with a specific chemotherapy regimen before surgery could better treat muscle-invasive bladder cancers with unusual cell types. The goal was to see if this combination could shrink or eliminate …
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Scientists test blood for cancer clues in bladder patients
Knowledge-focused CompletedThis study tested whether a blood test that looks for tiny pieces of cancer DNA could be used to monitor people with muscle-invasive bladder cancer. One participant undergoing standard treatment had their blood and urine collected at different times. The main goal was to see if c…
Matched conditions: MUSCLE INVASIVE BLADDER CARCINOMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:06 UTC